Over the past 12 months, 5 insiders at REGENERON PHARMACEUTICALS, INC. filed 47 open-market SEC Form 4 transactions on REGN: 0 purchases worth $0 and 47 sales worth $9.4M. Insiders have been net sellers over this period. The most recent filing was on Jul 2, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 2, 26 | Arthur F Ryan | SELL | 200 | $650.15 | $130K |
| Mar 2, 26 | Arthur F RyanDirector | SELL | 20 | $788.96 | $16K |
| Feb 19, 26 | Huda Y ZoghbiDirector | SELL | 331 | $790.00 | $258K |
| Feb 9, 26 | Jason PitofskySVP Controller | SELL | 563 | $785.72 | $438K |
| Feb 9, 26 | Arthur F RyanDirector | SELL | 57 | $786.29 | $44K |
| Jan 7, 26 | Bonnie L BasslerDirector | SELL | 1.5K | $800.00 | $1.2M |
| Nov 20, 25 | Bonnie L BasslerDirector | SELL | 760 | $750.00 | $570K |
| Nov 7, 25 | Jason PitofskyVP Controller | SELL | 431 | $651.43 | $281K |
| Oct 29, 25 | Christine A PoonDirector | SELL | 2.7K | $657.29 | $1.8M |
| Nov 1, 24 | Marion McCourtEVP Commercial | SELL | 1.0K | $844.61 | $845K |
| Oct 1, 24 | Marion McCourtEVP Commercial | SELL | 1.0K | $1054.06 | $1.1M |
| Oct 1, 24 | Arthur F RyanDirector | SELL | 12 | $1057.38 | $13K |
| Sep 3, 24 | Marion McCourtEVP Commercial | SELL | 1.0K | $1178.73 | $1.2M |
| Sep 3, 24 | Arthur F RyanDirector | SELL | 16 | $1190.00 | $19K |
| Aug 28, 24 | Christopher R. FenimoreSVP Finance & CFO | SELL | 2.2K | $1206.30 | $2.7M |
| Aug 15, 24 | Bonnie L BasslerDirector | SELL | 756 | $1170.00 | $885K |
| Aug 15, 24 | Christine A PoonDirector | SELL | 5.4K | $1161.32 | $6.2M |
| Aug 14, 24 | Andrew J MurphyEVP Research | SELL | 1.0K | $1159.69 | $1.2M |
| Aug 8, 24 | Neil StahlEVP Research and Development | SELL | 1.9K | $1086.15 | $2.0M |
| Aug 7, 24 | Jason PitofskyVP Controller | SELL | 487 | $1070.00 | $521K |
| Aug 2, 24 | Bonnie L BasslerDirector | SELL | 756 | $1115.00 | $843K |
| Aug 1, 24 | Marion McCourtEVP Commercial | SELL | 1.1K | $1060.86 | $1.2M |
| Aug 1, 24 | Arthur F RyanDirector | SELL | 13 | $1100.03 | $14K |
| Jul 11, 24 | Joseph J LarosaEVP General Counsel and Secret | SELL | 1.9K | $1088.95 | $2.0M |
| Jul 1, 24 | Marion McCourtEVP Commercial | SELL | 1.1K | $1047.11 | $1.2M |
| Jul 1, 24 | Arthur F RyanDirector | SELL | 19 | $1066.59 | $20K |
| Jun 24, 24 | Bonnie L BasslerDirector | SELL | 756 | $1062.00 | $803K |
| Jun 14, 24 | Michael S BrownDirector | SELL | 1.5K | $1040.00 | $1.6M |
| Jun 12, 24 | Leonard S SchleiferBd. Co-Chair, President & CEO | SELL | 14.9K | $1025.27 | $15.1M |
| Jun 11, 24 | Leonard S SchleiferBd. Co-Chair, President & CEO | SELL | 7.3K | $1016.04 | $7.4M |
| Jun 6, 24 | Leonard S SchleiferBd. Co-Chair, President & CEO | SELL | 787 | $1015.02 | $799K |
| Jun 5, 24 | Bonnie L BasslerDirector | SELL | 827 | $1011.00 | $836K |
| Jun 3, 24 | Marion McCourtEVP Commercial | SELL | 1.1K | $980.16 | $1.1M |
| Jun 3, 24 | Arthur F RyanDirector | SELL | 15 | $998.44 | $15K |
| May 28, 24 | Michael S BrownDirector | SELL | 1.2K | $974.86 | $1.1M |
| May 21, 24 | Joseph J LarosaEVP General Counsel and Secret | SELL | 1.9K | $994.90 | $1.9M |
| May 17, 24 | Leonard S SchleiferBd. Co-Chair, President & CEO | SELL | 22.7K | $980.07 | $22.2M |
| May 16, 24 | George YancopoulosBd. Co-Chair, President & CSO | SELL | 9.5K | $978.18 | $9.2M |
| May 15, 24 | George YancopoulosBd. Co-Chair, President & CSO | SELL | 9.9K | $989.14 | $9.6M |
| May 15, 24 | Leonard S SchleiferBd. Co-Chair, President & CEO | SELL | 7.9K | $988.76 | $7.7M |
| May 14, 24 | Leonard S SchleiferBd. Co-Chair, President & CEO | SELL | 22.7K | $980.10 | $22.2M |
| May 1, 24 | Marion McCourtEVP Commercial | SELL | 250 | $889.41 | $222K |
| May 1, 24 | Arthur F RyanDirector | SELL | 17 | $910.47 | $15K |
| Apr 1, 24 | Marion McCourtEVP Commercial | SELL | 250 | $964.73 | $241K |
| Apr 1, 24 | Arthur F RyanDirector | SELL | 20 | $965.35 | $19K |
| Mar 14, 24 | Andrew J MurphyEVP Research | SELL | 1.1K | $968.20 | $1.1M |
| Mar 1, 24 | Marion McCourtEVP Commercial | SELL | 358 | $967.50 | $346K |
| Mar 1, 24 | Arthur F RyanDirector | SELL | 19 | $987.33 | $19K |
| Feb 26, 24 | Bonnie L BasslerDirector | SELL | 854 | $979.25 | $836K |
| Feb 26, 24 | Joseph J LarosaEVP General Counsel and Secret | SELL | 1.0K | $990.00 | $990K |
Over the past 12 months, insiders at REGENERON PHARMACEUTICALS, INC. filed 0 open-market purchases worth $0 and 47 sales worth $9.4M on REGN, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 2, 26.
5 different insiders at REGENERON PHARMACEUTICALS, INC. filed open-market SEC Form 4 transactions on REGN over the last 12 months.
InsiderTape plots every REGN insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every REGENERON PHARMACEUTICALS, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →